Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T
Department of Neurological Surgery, Ehime University School of Medicine, Japan.
Stroke. 1994 Feb;25(2):298-303. doi: 10.1161/01.str.25.2.298.
Thrombolytic therapy was carried out on patients with acute ischemic stroke, and the risk of hemorrhagic transformation was evaluated from the residual cerebral blood flow (CBF) by pretherapeutic single-photon emission-computed tomography (SPECT).
Local intra-arterial thrombolytic therapy was carried out using urokinase or recombinant tissue plasminogen activator (rt-PA) within 6 hours from the onset in 34 patients in whom no hypodensity areas were observed on the initial computed tomography examination. In the 20 patients with carotid territory occlusion who underwent 99mTc-labeled hexamethylpropyleneamine oxime (99mTc-HMPAO) SPECT, the residual CBF of the ischemic region was evaluated semiquantitatively by calculating two parameters: the ischemic regional activity to cerebellar activity ratio (R/CE ratio) and asymmetry index (AI).
The occluded vessels could be recanalized in 22 (92%) of the 24 patients in the urokinase group and in all 10 of the patients in the rt-PA group. Hemorrhagic transformation appeared in 4 patients in the urokinase group and 3 patients in the rt-PA group. Among the 20 patients who underwent SPECT before the treatment, the residual CBF was lower in the 5 patients who developed hemorrhagic transformation than in the 15 who did not (P < .05). Hemorrhagic transformation occurred in all patients with R/CE ratio of less than 0.35 and AI of more than 1.5.
The risk of hemorrhagic transformation after recanalization of occluded vessels by local intra-arterial thrombolytic therapy was considered to be high when the pretherapeutic residual CBF was markedly reduced.
对急性缺血性脑卒中患者进行溶栓治疗,并通过治疗前单光子发射计算机断层扫描(SPECT)评估脑血流量(CBF)残余量,以评价出血性转化的风险。
对34例初始计算机断层扫描检查未见低密度区的患者,在发病6小时内使用尿激酶或重组组织型纤溶酶原激活剂(rt-PA)进行局部动脉内溶栓治疗。在20例接受99mTc标记的六甲基丙烯胺肟(99mTc-HMPAO)SPECT检查的颈动脉供血区闭塞患者中,通过计算缺血区活性与小脑活性比值(R/CE比值)和不对称指数(AI)这两个参数,对缺血区域的残余CBF进行半定量评估。
尿激酶组24例患者中有22例(92%)闭塞血管再通,rt-PA组10例患者全部再通。尿激酶组有4例患者、rt-PA组有3例患者出现出血性转化。在治疗前行SPECT检查的20例患者中,发生出血性转化的5例患者的残余CBF低于未发生出血性转化的15例患者(P<0.05)。R/CE比值小于0.35且AI大于1.5的所有患者均发生出血性转化。
当治疗前残余CBF显著降低时,局部动脉内溶栓治疗使闭塞血管再通后发生出血性转化的风险较高。